| 1. Have you received any formal training or
education on pharmacogenomics? |
| Yes |
18 (24) |
| Unsure |
1 (1.3) |
| No |
56 (74.7) |
| 2. How comfortable do you feel recommending
pharmacogenomic tests to providers and patients? |
| Very comfortable |
5 (6.7) |
| Somewhat comfortable |
12 (16) |
| Neither comfortable nor uncomfortable |
9 (12) |
| Somewhat uncomfortable |
21 (28) |
| Very uncomfortable |
28 (37.3) |
| 3. How comfortable are you interpreting the
results of a pharmacogenomic test? |
| Very comfortable |
4 (5.3) |
| Somewhat comfortable |
15 (20) |
| Neither comfortable nor uncomfortable |
10 (13.3) |
| Somewhat uncomfortable |
16 (21.3) |
| Very uncomfortable |
30 (40) |
| 4. How comfortable do you feel providing
recommendations to a provider or patient based on pharmacogenomic
results? |
| Very comfortable |
4 (5.3) |
| Somewhat comfortable |
12 (16) |
| Neither comfortable nor uncomfortable |
15 (20) |
| Somewhat uncomfortable |
18 (24) |
| Very uncomfortable |
26 (34.7) |
| 5. How would you assess your current
knowledge of pharmacogenomic resources and guidelines? |
| Knowledgeable |
5 (6.7) |
| Somewhat knowledgeable |
23 (30.7) |
| Not knowledgeable |
44 (58.7) |
| Unsure |
2 (2.7) |
| Not reported |
1 (1.3) |
| 6. Which sources would you consult when
interpreting pharmacogenetic test results? |
| Medical Association
Meetings/Guidelines/Recommendations |
29 (38.7) |
| Scientific Literature |
35 (46.7) |
| Drug Resources (e.g. Micromedex, Lexicomp, etc.) |
48 (64) |
| Internet |
21 (28) |
| Drug Labeling/FDA website |
22 (29.3) |
| Colleague with expertise |
39 (52) |
| Other |
6 (8) |
| 7. Has a patient or provider brought a
pharmacogenomic test result to you for guidance in medication dosing
or selection or to explain previous medication experiences? |
| Yes |
12 (16) |
| Unsure |
2 (2.7) |
| No |
61 (81.3) |
| 8. How significant of an impact do you
believe pharmacogenomics has on current practice? |
| Very significant |
12 (16) |
| Somewhat significant |
31 (41.3) |
| Neither significant nor insignificant |
10 (13.3) |
| Somewhat insignificant |
14 (18.7) |
| Very insignificant |
8 (10.7) |
| 9. How would (have) you document(ed)
pharmacogenomic test results in a patient’s electronic
medical record? (Check all that apply) |
| Enter notes into electronic health record |
25 (33.3) |
| Scan test results into the electronic health
record |
24 (32) |
| List major findings as an allergy |
14 (18.7) |
| List major findings in the problem list |
13 (17.3) |
| Flagging a medication that has CPIC guidance |
10 (13.3) |
| Unsure |
44 (58.7) |
| Other |
5 (6.7) |
| If other, please describe: |
| • Add a flag to the header
in the patient chart along with allergies, ht, wt, CrCl, etc. |
| • Ivent of recommendations,
did not scan information into chart |
| • Kept out of chart due to
current protocol issues |
| • Lab results |
| • Near microbiology section
in results |
| 10. Do you support offering pharmacogenomic
testing and interpretation though Pharmacy Services? |
| Yes |
54 (72) |
| Unsure |
19 (25.3) |
| No |
2 (2.7) |
| 11. Would you want a decision support tool
to alert you to potential drug-gene interactions in patients with
pharmacogenomic results? |
| Yes |
67 (89.3) |
| Unsure |
8 (10.7) |
| 12. What barriers do you think are
preventing/slowing the implementation of pharmacogenomic
services? |
| Insurance |
44 (58.7) |
| Willingness to take on a new task |
23 (30.7) |
| Education |
66 (88) |
| Process of ordering to putting in the medical
record |
32 (42.7) |
| Limited resources for interpretation and application
of pharmacogenomic test results |
58 (77.3) |
| 13. Do you agree with the following
statement: Pharmacists are the best suited clinicians to implement
pharmacogenomic testing. |
| Yes |
44 (58.7) |
| Unsure |
29 (38.7) |
| No |
2 (2.7) |
| If yes, where within the practice of
pharmacy is pharmacogenomics the best suited? |
| Acute and Ambulatory |
2 (5.4) |
| Ambulatory Care |
17 (45.9) |
| Clinical Pharmacists |
7 (18.9) |
| Multiple areas of pharmacy |
3 (8.1) |
| Specialists that achieved certification |
1 (2.7) |
| Specialty Clinics (behavioral health, oncology,
neurology, cardiovascular) |
6 (16.2) |
| Unsure |
1 (2.7) |
